Apitope Technology (Bristol) Ltd.

Apitope Technology (Bristol) Ltd (Apitope, the Company) is a biopharmaceutical company aiming to become a world leader in the treatment of allergy and autoimmune diseases with novel advantaged products representing major advances in therapy and addressing critical unmet needs.

Founded at the University of Bristol in January 2002, the Company has established itself with an impressive record of commercial and technical achievement through highly qualified, inspired and enthusiastic management and scientists.